In the second of his three-part Pharmaceutical Commerce interview, Jay Bregman discusses how rising demand for GLP-1 therapies is challenging employers to reassess how they manage ...
In today's Pharma Pulse, ongoing conflict in the Middle East disrupts critical pharmaceutical cold chains, while AstraZeneca and partners launch a new program to decarbonize industrial heat across ...